C. Hulin
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 10
- Multiple Myeloma Research and Treatments 10
- Oncology 7
- Cancer Treatment and Pharmacology 5
- Co-authors
- Philippe Moreau (7 shared papers)Hervé Avet‐Loiseau (3 shared papers)Thierry Façon (5 shared papers)Philippe Casassus (2 shared papers)Laurent Garderet (2 shared papers)Laurent Voillat (3 shared papers)Pascal Godmer (1 shared paper)Stéphane Minvielle (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Haematologica (2 papers)Blood (2 papers)European Journal of Internal Medicine (1 paper)Leukemia (1 paper)
- Partner nations
- FranceUnited StatesCzechia
In The Last Decade
C. Hulin
14 papers receiving 186 citations
Peers
Comparison fields: 5 of 38
- Hematology 161
- Oncology 92
- Molecular Biology 141
- Genetics 20
- Cancer Research 19
Countries citing papers authored by C. Hulin
This map shows the geographic impact of C. Hulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hulin more than expected).
Fields of papers citing papers by C. Hulin
This network shows the impact of papers produced by C. Hulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hulin. The network helps show where C. Hulin may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Hulin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 83 | |
| 2 | 2011 | 43 | |
| 3 | 2004 | 20 | |
| 4 | 2007 | 15 | |
| 5 | 2008 | 9 | |
| 6 | [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia]. | 2002 | 8 |
| 7 | 2008 | 2 | |
| 8 | 2008 | 2 | |
| 9 | HEALTH RESOURCE UTILIZATION WITH CONTINUOUS LENALIDOMIDE TREATMENT (TX) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) | 2015 | 1 |
| 10 | 2014 | 1 | |
| 11 | 1999 | 1 | |
| 12 | 2007 | 1 | |
| 13 | 2004 | 1 | |
| 14 | 2021 | 1 | |
| 15 | [Diagnosis of lymphoid hemopathy at the time of the diagnosis of cryoglobulinemia]. | 2001 | 0 |
| 16 | 2009 | 0 |
About C. Hulin
C. Hulin is a scholar working on Hematology, Oncology, Molecular Biology, Surgery and Emergency Medicine, having authored 16 papers that have together received 188 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers), Protein Degradation and Inhibitors (2 papers), Cancer therapeutics and mechanisms (2 papers), Hematological disorders and diagnostics (2 papers), Chemical synthesis and alkaloids (1 paper), Cytomegalovirus and herpesvirus research (1 paper) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Hematology (161 citations), Oncology (92 citations), Molecular Biology (141 citations), Genetics (20 citations) and Cancer Research (19 citations). C. Hulin has collaborated with scholars based in France, United States and Czechia. Frequent co-authors include Philippe Moreau, Hervé Avet‐Loiseau, Thierry Façon, Philippe Casassus, Laurent Garderet, Laurent Voillat, Pascal Godmer, Stéphane Minvielle, Laurence Lodé and Nikhil Munshi. Their work appears in journals such as Journal of Clinical Oncology, Haematologica, Blood, European Journal of Internal Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.